This webinar provides an overview of the current neoadjuvant management of HER2-positive breast cancer and its implications for surgical decision-making. Experts will discuss evidence-based standards of care, key considerations in tailoring neoadjuvant therapy, and the evolving role of surgery after systemic treatment. The session aims to offer practical insights for clinicians involved in the multidisciplinary management of HER2+ breast cancer.